Active substance:
- Canarypox virus, strain vCP3011, expressing haemagglutinin gene of Influenza A virus subtype H3N8 (A/equine/Richmond/1/2007), Live
- Canarypox virus, strain vCP2242, expressing haemagglutinin gene of Influenza A virus subtype H3N8 (A/equine/Ohio/03), Live
- Clostridium tetani, toxoid
Route of administration:
-
Intramuscular use
Pharmaceutical form:
-
Suspension for injection
Target species:
-
Horse
Available in:
-
Austria
-
Belgium
-
Czechia
-
France
-
Germany
-
Luxembourg
-
Slovakia
-
Spain